Lansoprazol Kern Pharma

Lansoprazole, the active ingredient in Lansoprazol Kern Pharma, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Lansoprazol Kern Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief in several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation. - Erosive oesophagitis: promotes healing of inflamed esophageal tissue. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication (as part of combination therapy): enhances bacterial clearance. - Zollinger‑Ellison syndrome: controls excessive gastric acid production.

Lansoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: jaundice or abnormal liver tests. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy, consider the following precautions. - Assess renal function: adjust use in severe renal impairment. - Evaluate hepatic status: use cautiously in liver disease. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term use: assess need for continued therapy after 12 months. - Pregnancy and lactation: discuss risks with prescriber; data are limited. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Lansoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect; consider alternative therapy. - Atazanavir or other protease inhibitors: markedly decreased absorption.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Methotrexate: reduced clearance; watch for toxicity. - Digoxin: increased serum levels; adjust dose if needed. - Diazepam: enhanced sedation; monitor CNS effects.